Point72 Hong Kong LTD Editas Medicine, Inc. Transaction History

Point72 Hong Kong LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $3,125 - $5,555	500 New	500 $5,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $245,923 - $392,750	20,224 New	20,224 $248,000
Q1 2022 May 16, 2022	SELL	$14.08 - $27.63 $41,324 - $81,094	-2,935 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $77,924 - $119,072	2,935 New	2,935 $78,000
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $275,793 - $512,257	-7,023 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $157,576 - $285,239	5,036 Added 253.45%	7,023 $398,000
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $34,746 - $79,257	875 Added 78.69%	1,987 $83,000
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $3,058 - $9,531	-113 Reduced 9.22%	1,112 $78,000
Q3 2020 Nov 16, 2020	BUY	$28.06 - $37.16 $34,373 - $45,520	1,225 New	1,225 $34,000
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $1,860 - $4,097	-125 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $2,436 - $4,078	125 New	125 $4,000
Q4 2018 Feb 14, 2019	SELL	$18.19 - $31.79 $26,575 - $46,445	-1,461 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $40,396 - $56,087	1,461 New	1,461 $46,000
Q2 2018 Aug 14, 2018	SELL	$31.4 - $41.01 $38,684 - $50,524	-1,232 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $36,762 - $54,306	1,232 New	1,232 $41,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.